EPIX Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

EPIX Therapeutics General Information

Description

Developer of a next-generation ablation catheter technology designed to treat Atrial Fibrillation. The company helps to improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system, enabling patients with a medical device to treat irregular heart rhythms.

Contact Information

Website
www.actmed.net
Formerly Known As
Advanced Cardiac Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2880 Lakeside Drive
  • Suite 250
  • Santa Clara, CA
  • United States
Primary Industry
Surgical Devices
Acquirer
Siemens Healthineers
Corporate Office
  • 2880 Lakeside Drive
  • Suite 250
  • Santa Clara, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EPIX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Jul-2023 Completed Generating Revenue
8. Merger/Acquisition 01-Mar-2019 Completed Generating Revenue
7. Later Stage VC (Series C) 27-Sep-2018 Completed Generating Revenue
6. Later Stage VC (Series B) 02-May-2017 Completed Product Development
5. Later Stage VC (Series A2) 10-Apr-2014 Completed Product Development
4. Early Stage VC 29-Aug-2011 Completed Product Development
3. Early Stage VC (Series B) 11-Nov-2010 Completed Product Development
2. Early Stage VC 21-Oct-2010 $1.2M $1.55M Completed Startup
1. Early Stage VC (Series A) 18-Mar-2009 $350K $350K Completed Startup
To view EPIX Therapeutics’s complete valuation and funding history, request access »

EPIX Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A2
Series A1 1,657,982 $0.001000 $0.08 $1.05 $1.05 1x $1.05 3.77%
Series 1 338,545 $0.001000 $0.11 $1.43 $1.43 1x $1.43 0.77%
To view EPIX Therapeutics’s complete cap table history, request access »

EPIX Therapeutics Patents

EPIX Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3860484-A1 Lesion formation assessment and display Pending 05-Oct-2018
US-11642166-B2 Lesion formation assessment and display Active 05-Oct-2018
US-12349965-B2 Lesion formation assessment and display Active 05-Oct-2018
US-20200107877-A1 Lesion formation assessment and display Active 05-Oct-2018
US-20230248427-A1 Lesion formation assessment and display Active 05-Oct-2018 A61B18/1492
To view EPIX Therapeutics’s complete patent history, request access »

EPIX Therapeutics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ajax Health PE/Buyout Minority
Hansen Medical Corporation Minority
Keiretsu Forum Angel Group Minority
Life Science Angels Angel Group Minority
Medtronic Corporation Majority
You’re viewing 5 of 10 investors. Get the full list »

EPIX Therapeutics FAQs

  • When was EPIX Therapeutics founded?

    EPIX Therapeutics was founded in 2007.

  • Where is EPIX Therapeutics headquartered?

    EPIX Therapeutics is headquartered in Santa Clara, CA.

  • What industry is EPIX Therapeutics in?

    EPIX Therapeutics’s primary industry is Surgical Devices.

  • Is EPIX Therapeutics a private or public company?

    EPIX Therapeutics is a Private company.

  • What is EPIX Therapeutics’s current revenue?

    The current revenue for EPIX Therapeutics is .

  • How much funding has EPIX Therapeutics raised over time?

    EPIX Therapeutics has raised $77.8M.

  • Who are EPIX Therapeutics’s investors?

    Ajax Health, Hansen Medical, Keiretsu Forum, Life Science Angels, and Medtronic are 5 of 10 investors who have invested in EPIX Therapeutics.

  • When was EPIX Therapeutics acquired?

    EPIX Therapeutics was acquired on 01-Jul-2023.

  • Who acquired EPIX Therapeutics?

    EPIX Therapeutics was acquired by Siemens Healthineers.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process